ENDPOINTS

Surrozen raises $175M, to focus on ophthalmology; CBC Group has a new $1B fund

Plus, news about CG Oncology, Opus Genetics and Valneva: Surrozen’s pivot and capital raise: The South San Francisco drug developer is scrapping clinical development in severe alcohol associated hepatitis and instead ...

Mar 24, 2025 - 16:00
 0
Surrozen raises $175M, to focus on ophthalmology; CBC Group has a new $1B fund
Plus, news about CG Oncology, Opus Genetics and Valneva: Surrozen’s pivot and capital raise: The South San Francisco drug developer is scrapping clinical development in severe alcohol associated hepatitis and instead ...
Read More

Tags:

Previous Article

Gorgeous Hubble telescope image was 20 years in the making: Space photo of the day

Next Article

Private SpaceX Fram2 mission ready for world's 1st crewed flight over Earth's po...

Related Posts

Sorriso Pharmaceuticals outlines Phase 1b ulcerative colitis data for oral antibody

Sorriso Pharmaceuticals outlines Phase 1b ulcerative co...

Feb 27, 2025  0

Galatea Bio gets $25M to map genetic diversity of 10 million people, help pharma create new medicines

Galatea Bio gets $25M to map genetic diversity of 10 mi...

Mar 27, 2025  0

Belgian biotech Augustine gets $85M for neuro and cardiometabolic pills

Belgian biotech Augustine gets $85M for neuro and cardi...

Mar 24, 2025  0